Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jonghan Yu"'
Autor:
Isaac Kim, Jonghan Yu, Seok Won Kim, Se Kyung Lee, Hee Jun Choi, Seok Jin Nam, Jai Min Ryu, Jeong Eon Lee
Publikováno v:
Breast Cancer Research and Treatment. 176:591-596
Many breast cancer patients receive sentinel lymph node biopsy after neoadjuvant chemotherapy (NAC). We evaluated the axillary pathologic complete response (pCR) in relation to achievement of breast pCR. We evaluated 1044 patients who were diagnosed
Autor:
Seok Won Kim, Soo Youn Bae, Se Kyung Lee, Seok Jin Nam, Jonghan Yu, Jeong Eon Lee, Seung Pil Jung
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 34, Iss 12, Pp 663-672 (2018)
Mutations of the p53 gene are the most common genomic alterations associated with triple-negative breast cancer (TNBC) and are reported in 60–88% cases. Despite the high incidence of such mutations, there is no consensus about the clinical applicat
Autor:
Jeong Eon Lee, Jin Hyang Jung, Se Kyung Lee, Tae in Yoon, Soo Youn Bae, Hyouk Jin Lee, Eun Sook Lee, Soo Jung Lee, Byung Joo Chae, Seok Won Kim, Seok Jin Nam, Jai Min Ryu, Jonghan Yu
Publikováno v:
Breast Cancer Research and Treatment. 159:489-498
Tumor size and number of lymph node (LN) metastases are well known as the most important prognostic factors of breast cancer. We hypothesized that very small breast cancers with LN metastasis represent a progressive biologic behavior and evaluated tu
Autor:
Sung Mi Jung, Jeong Eon Lee, Byung Joo Chae, Se Kyung Lee, Seung Ki Min, Jai Min Ryu, Jonghan Yu, Seok Won Kim, Seok Jin Nam, Jinsun Woo
Publikováno v:
Journal of Breast Cancer
Purpose Tumor size and lymph node metastasis are important factors that contribute to the progression of breast cancer. We aimed to analyze the relationship between tumor size and lymph node metastasis molecular subtype and examine the effects of nod
Autor:
Soo Youn Bae, Hyun-June Paik, Jonghan Yu, Seok Won Kim, Jai Min Ryu, Seok Jin Nam, Sungmin Park, Jeong Eon Lee, Isaac Kim, Se Kyung Lee
Publikováno v:
Medicine
Luminal A breast cancer has a much better prognosis than other subtypes, with a low risk of local or regional recurrence. However, there is controversy around under- versus overtreatment with regard to adjuvant treatment of node-positive, luminal A b
Autor:
Seok Won Kim, Jeong Eon Lee, Jai Min Ryu, Se Hwan Han, Yong Sik Jung, Seok Jin Nam, Jonghan Yu, Jiyoung Kim, Se Kyung Lee
Publikováno v:
Clinical breast cancer. 17(7)
Axillary lymph node (ALN) status is an important prognostic factor for breast cancer patients. With increasing numbers of patients undergoing neoadjuvant chemotherapy (NAC), issues concerning sentinel lymph node biopsy (SLNB) after NAC have emerged.W
Autor:
Seok Won Kim, Seok Jin Nam, Jeong Eon Lee, Jai Min Ryu, Isaac Kim, Jonghan Yu, Se Kyung Lee, Hee Jun Choi, Jae-Myung Kim
Publikováno v:
Journal of Breast Cancer
Purpose The recent trend in breast cancer treatment is to minimize axillary dissection. However, no pattern of axillary metastasis has been precisely established. The purpose of this study was to evaluate the metastatic lymphatic pattern using near-i
Autor:
Se Kyung Lee, Jeong Eon Lee, Hyun-June Paik, Sungmin Park, Seok Jin Nam, Soo Youn Bae, Isaac Kim, Jai Min Ryu, Seok Won Kim, Jonghan Yu
Publikováno v:
Medicine
Conditional disease-free survival (CDFS) reflects changes over time. Because traditional disease-free survival (DFS) is estimated from the date of diagnosis, it is limited in the ability to predict risk of recurrence in patients who have been disease